A critical regulatory role for macrophage migration inhibitory factor in hyperoxia-induced injury in the developing

Huanxing Sun1, Rayman Choo-Wing, Angara Sureshbabu

  • 1Department of Pediatrics, Yale University, New Haven, Connecticut, United States of America.

Plos One
|May 3, 2013
PubMed
Abstract

Insights

Macrophage migration inhibitory factor (MIF) plays a role in neonatal lung injury from hyperoxia. Angiopoietins and Tie2 are involved in the MIF-regulated response to hyperoxia in developing lungs.

Area of Science:

  • Neonatal physiology
  • Pulmonary medicine
  • Molecular biology

Background:

  • The role of Macrophage Migration Inhibitory Factor (MIF) in hyperoxia-induced acute lung injury (HALI) in newborns is unknown.
  • MIF is hypothesized to be a critical regulator in HALI within the developing lung.

Purpose of the Study:

  • To investigate the role and mechanism of MIF in neonatal HALI.
  • To examine the relationship between MIF, Angiopoietins, and Tie2 in the neonatal lung under normoxia and hyperoxia.

Main Methods:

  • Studied wild type (WT), MIF knockout (MIFKO), and MIF lung transgenic (MIFTG) newborn mice.
  • Mice were exposed to room air or hyperoxia for 7 postnatal days.
  • Analyzed lung morphometry and expression of vascular mediators (mRNA and protein).

Main Results:

  • MIF expression increased in WT lungs with hyperoxia.
  • Angiopoietin 2 expression correlated with mortality patterns in hyperoxia (MIFKO > WT > MIFTG).
  • In normoxia, MIFKO and MIFTG showed altered lung structure and reduced Angiopoietin 1/Tie 2 expression compared to WT; these differences disappeared with hyperoxia.

Conclusions:

  • Data suggest Angiopoietins 1, 2, and their receptor Tie2 are involved in the MIF-regulated response.
  • These factors are implicated in both normoxic and hyperoxic conditions in the neonatal lung.